Nuveen Dow 30 Dynamic Overwrite Fund
DIAX · NYSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $5 | $47 | $6 | $6 |
| % Growth | -88.8% | 716.8% | -7.9% | – |
| Cost of Goods Sold | $0 | $3 | $5 | $0 |
| Gross Profit | $5 | $44 | $1 | $6 |
| % Margin | 100% | 94.3% | 9.6% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $3 | -$10 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $12 | $0 |
| Operating Expenses | $3 | -$10 | $15 | $3 |
| Operating Income | $2 | $54 | $3 | $3 |
| % Margin | 47.7% | 114.8% | 51.8% | 56.4% |
| Other Income/Exp. Net | -$5 | $51 | $5 | $33 |
| Pre-Tax Income | -$2 | $54 | $8 | $36 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | $54 | $8 | $36 |
| % Margin | -42.9% | 114.8% | 131.2% | 580.1% |
| EPS | -0.062 | 1.47 | 0.21 | 0.99 |
| % Growth | -104.2% | 600% | -78.8% | – |
| EPS Diluted | -0.062 | 1.47 | 0.21 | 1 |
| Weighted Avg Shares Out | 36 | 36 | 36 | 73 |
| Weighted Avg Shares Out Dil | 36 | 36 | 36 | 73 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$2 | -$3 | -$3 | -$3 |
| EBITDA | $0 | $54 | $8 | $0 |
| % Margin | 0% | 114.8% | 131.2% | 0% |